{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T07:08:05Z","timestamp":1773385685447,"version":"3.50.1"},"reference-count":24,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vox Sanguinis"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and Objectives<\/jats:title>\n                    <jats:p>Tranexamic acid (TXA) as an adjunct to prophylactic platelet transfusion is sometimes used to prevent bleeding in patients with malignancies experiencing chemotherapy\u2010induced thrombocytopenia. However, there is little biological evidence in support. This pilot exploratory study aimed to evaluate the haemostatic efficacy of TXA before and after platelet transfusion versus platelet transfusion alone in patients with haematological malignancies experiencing chemotherapy\u2010induced thrombocytopenia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>Rotational thromboelastometry (ROTEM; EXTEM, tissue plasminogen activator [tPA]\u2010EXTEM and FIBTEM) was used to assess the haemostatic effect of these treatments.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Eighteen patients were randomized to receive platelet transfusion and either 3 or 1.5\u2009g of TXA per day or to be observed. At enrolment, ROTEM parameters were similar across groups. TXA alone did not affect EXTEM clot formation time (CFT) or maximum clot firmness (MCF). A trend towards increased EXTEM CFT and MCF values 2 h after platelet transfusion was observed. The effect of TXA was witnessed by the increase in tPA\u2010EXTEM lysis index\u2009at 60\u2009min (LI60). In the observation group, tPA\u2010EXTEM LI60 also significantly increased after platelet transfusion. The World Health Organization (WHO) rates for grade \u22652 bleeding and the median number of platelet transfusions were similar across all groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Platelet transfusion as well as TXA decreased fibrinolysis for this patient population. This could be explained by the plasminogen activator inhibitor 1 contained in platelets. Future research should explore other alternative treatments and the utility of viscoelastometric testing to guide platelet transfusions, particularly in cases of bleeding or platelet transfusion refractoriness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/vox.70165","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T02:45:48Z","timestamp":1765766748000},"page":"298-308","source":"Crossref","is-referenced-by-count":0,"title":["Thromboelastometric assessment of the haemostatic effect of tranexamic acid as an adjunct to prophylactic platelet transfusions in patients with haematological malignancies undergoing intensive chemotherapy: A pilot study"],"prefix":"10.1111","volume":"121","author":[{"given":"Guillaume","family":"Simoens","sequence":"first","affiliation":[{"name":"SAINBIOSE UMR 1059, INSERM, Jean Monnet University  Saint\u2010Etienne France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Daguenet","sequence":"additional","affiliation":[{"name":"Division of Clinical Hematology University Hospital of Saint\u2010Etienne  Saint\u2010Etienne France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Audrey","family":"Tientcheu","sequence":"additional","affiliation":[{"name":"SAINBIOSE UMR 1059, INSERM, Jean Monnet University  Saint\u2010Etienne France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Fatrara","sequence":"additional","affiliation":[{"name":"Division of Clinical Hematology University Hospital of Saint\u2010Etienne  Saint\u2010Etienne France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Tardy","sequence":"additional","affiliation":[{"name":"Clinical Investigation Center CIC\u2010EC 1408 University Hospital of Saint\u2010Etienne  Saint\u2010Etienne France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9r\u00f4me","family":"Cornillon","sequence":"additional","affiliation":[{"name":"Division of Clinical Hematology University Hospital of Saint\u2010Etienne  Saint\u2010Etienne France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Tavernier","sequence":"additional","affiliation":[{"name":"Division of Clinical Hematology University Hospital of Saint\u2010Etienne  Saint\u2010Etienne France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Lecompte","sequence":"additional","affiliation":[{"name":"Faculty of Medicine University of Lorraine  Nancy France"},{"name":"Vascular Medicine Division University Hospital  Nancy France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinne","family":"Frere","sequence":"additional","affiliation":[{"name":"Division of Laboratory Hematology Piti\u00e9 Salp\u00eatri\u00e8re\u2010Charles\u2010Foix, AP\u2010HP  Paris France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0879-6261","authenticated-orcid":false,"given":"Emilie","family":"Chalayer","sequence":"additional","affiliation":[{"name":"SAINBIOSE UMR 1059, INSERM, Jean Monnet University  Saint\u2010Etienne France"},{"name":"Division of Clinical Hematology University Hospital of Saint\u2010Etienne  Saint\u2010Etienne France"},{"name":"Clinical Investigation Center CIC\u2010EC 1408 University Hospital of Saint\u2010Etienne  Saint\u2010Etienne France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,12,14]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-10-97"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2022016558"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60689-8"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0904084"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1212772"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.2003.00326.x"},{"key":"e_1_2_9_8_1","first-page":"78","article-title":"In vitro evaluation of clot quality and stability in a model of severe thrombocytopenia: effect of fibrinogen, factor XIII and thrombin\u2010activatable fibrinolysis inhibitor","volume":"12","author":"Shenkman B","year":"2014","journal-title":"Blood Transfus"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12928"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12331"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14465"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14120"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90181-5"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199509059668"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00317-X"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-016-0076-2"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1213\/ane.0b013e3181966675"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000000738"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.14378"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/anae.13270"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17820"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.2.351.351"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022008255"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-019-2347-3"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0000000000000463"}],"container-title":["Vox Sanguinis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vox.70165","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/vox.70165","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/vox.70165","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T02:07:34Z","timestamp":1773367654000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/vox.70165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,14]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1111\/vox.70165"],"URL":"https:\/\/doi.org\/10.1111\/vox.70165","archive":["Portico"],"relation":{},"ISSN":["0042-9007","1423-0410"],"issn-type":[{"value":"0042-9007","type":"print"},{"value":"1423-0410","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,14]]}}}